• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长激素释放因子和胰岛素低血糖对人体生长激素释放的相加作用。

Additive effects of growth hormone releasing factor and insulin hypoglycaemia on growth hormone release in man.

作者信息

Page M D, Koppeschaar H P, Edwards C A, Dieguez C, Scanlon M F

机构信息

Department of Medicine, University of Wales College of Medicine, Heath Park, Cardiff.

出版信息

Clin Endocrinol (Oxf). 1987 May;26(5):589-95. doi: 10.1111/j.1365-2265.1987.tb00814.x.

DOI:10.1111/j.1365-2265.1987.tb00814.x
PMID:3117447
Abstract

We have measured GH and PRL changes following separate and combined administration of insulin and GH releasing factor (GRF) in six normal males. Peak GH responses to separate administration of insulin and GRF were comparable (71.4 +/- 10.2 vs 70.1 +/- 27.7 mU/l; mean +/- SEM). However, the peak GH response following combined administration was significantly higher (120.8 +/- 29.7, P less than 0.05) as was the total GH released as calculated by measuring the area under the curve (P less than 0.05). In contrast the PRL response to hypoglycaemia was not altered by the combined administration of insulin and GRF. This effect was not due to any direct action of hypoglycaemia or insulin at pituitary level since basal and 10(-8) M GRF stimulated GH release from rat anterior pituitary cells in vitro was not influenced by varying glucose and insulin levels. Our findings support the hypothesis that GRF and insulin-induced hypoglycaemia release GH via different pathways which are, at least in part, additive.

摘要

我们测定了6名正常男性分别单独及联合给予胰岛素和生长激素释放因子(GRF)后生长激素(GH)和催乳素(PRL)的变化。单独给予胰岛素和GRF时,GH的峰值反应相当(分别为71.4±10.2与70.1±27.7 mU/l;均值±标准误)。然而,联合给药后的GH峰值反应显著更高(120.8±29.7,P<0.05),通过测量曲线下面积计算得出的总GH释放量也更高(P<0.05)。相比之下,联合给予胰岛素和GRF并未改变PRL对低血糖的反应。这种效应并非由于低血糖或胰岛素在垂体水平的任何直接作用,因为体外培养的大鼠垂体前叶细胞在基础状态及10(-8)M GRF刺激下的GH释放不受葡萄糖和胰岛素水平变化的影响。我们的研究结果支持以下假说:GRF和胰岛素诱导的低血糖通过不同途径释放GH,这些途径至少部分是相加的。

相似文献

1
Additive effects of growth hormone releasing factor and insulin hypoglycaemia on growth hormone release in man.生长激素释放因子和胰岛素低血糖对人体生长激素释放的相加作用。
Clin Endocrinol (Oxf). 1987 May;26(5):589-95. doi: 10.1111/j.1365-2265.1987.tb00814.x.
2
Synergistic interaction in bovine pituitary cultures between growth hormone-releasing factor and other hypophysiotrophic factors.
J Endocrinol. 1986 Apr;109(1):67-74. doi: 10.1677/joe.0.1090067.
3
Biphasic action of forskolin on growth hormone and prolactin secretion by rat anterior pituitary cells in vitro.福司可林对体外培养的大鼠垂体前叶细胞生长激素和催乳素分泌的双相作用。
Endocrinology. 1990 Oct;127(4):1811-7. doi: 10.1210/endo-127-4-1811.
4
A divergence of plasma growth hormone response between growth hormone-releasing factor and insulin-induced hypoglycaemia among middle-aged healthy male subjects.中年健康男性受试者中,生长激素释放因子与胰岛素诱发低血糖所引起的血浆生长激素反应的差异。
Clin Endocrinol (Oxf). 1986 Mar;24(3):279-83. doi: 10.1111/j.1365-2265.1986.tb03268.x.
5
Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.人胰腺肿瘤生长激素释放因子:正常人体内的剂量反应关系
J Clin Endocrinol Metab. 1984 May;58(5):838-44. doi: 10.1210/jcem-58-5-838.
6
Potency and specificity of a growth hormone-releasing factor in a primate and in vitro.一种生长激素释放因子在灵长类动物体内及体外的效能与特异性
J Clin Endocrinol Metab. 1984 Feb;58(2):309-12. doi: 10.1210/jcem-58-2-309.
7
Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.生长激素释放因子对垂体功能减退儿童和正常矮身材儿童血浆生长激素、催乳素及生长调节素C的影响
Horm Res. 1985;22(1-2):32-45. doi: 10.1159/000180069.
8
Effect of long-term administration of porcine growth hormone-releasing factor and(or) thyrotropin-releasing factor on growth hormone, prolactin and thyroxine concentrations in growing pigs.
J Anim Sci. 1990 Jan;68(1):95-107. doi: 10.2527/1990.68195x.
9
Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.遗传性肥胖Zucker大鼠生长激素分泌受损的机制:生长激素释放因子和生长抑素的作用。
Endocrinology. 1990 Dec;127(6):3087-95. doi: 10.1210/endo-127-6-3087.
10
Modulation of growth hormone-releasing factor stimulated growth hormone secretion by plasma glucose and free fatty acid concentrations in sheep.血浆葡萄糖和游离脂肪酸浓度对绵羊生长激素释放因子刺激生长激素分泌的调节作用
Neuroendocrinology. 1988 Dec;48(6):627-33. doi: 10.1159/000125073.

引用本文的文献

1
Diversity and structural-functional insights of alpha-solenoid proteins.α-螺旋蛋白的多样性和结构功能见解。
Protein Sci. 2024 Nov;33(11):e5189. doi: 10.1002/pro.5189.
2
The inhibitory effect of glucose on growth hormone secretion is lost in obesity but not in hypertension.葡萄糖对生长激素分泌的抑制作用在肥胖症中消失,但在高血压中并未消失。
J Endocrinol Invest. 1997 Nov;20(10):616-20. doi: 10.1007/BF03346919.
3
The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people.
血清素激动剂右芬氟拉明长期给药对中度肥胖人群促肾上腺皮质激素释放激素和生长激素释放激素反应性的影响。
J Endocrinol Invest. 1995 Nov;18(10):780-8. doi: 10.1007/BF03349811.
4
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.内源性生长激素释放激素是生长激素对药理刺激产生反应所必需的。
J Clin Invest. 1996 Feb 15;97(4):934-40. doi: 10.1172/JCI118516.
5
Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.人类生长激素分泌的神经内分泌调节。诊断及临床应用。
J Endocrinol Invest. 1988 Jun;11(6):441-62. doi: 10.1007/BF03349081.
6
Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects.降脂药物阿西莫司对正常受试者生长激素(GH)释放激素刺激的生长激素(GH)反应的影响。
J Endocrinol Invest. 1990 Jun;13(6):539-42. doi: 10.1007/BF03348621.
7
Growth hormone release during insulin tolerance, clonidine, arginine and growth hormone releasing hormone tests in short normal children and adolescents.
J Endocrinol Invest. 1992 Feb;15(2):131-5. doi: 10.1007/BF03348678.